Ignite Creation Date:
2024-05-06 @ 9:34 AM
Last Modification Date:
2024-10-26 @ 12:16 PM
Study NCT ID:
NCT03016468
Status:
WITHDRAWN
Last Update Posted:
2017-04-11
First Post:
2017-01-06
Brief Title:
Safety of Transition From Selexipag to Remodulin Then Oral Treprostinil in Symptomatic Adult PAH
Sponsor:
United Therapeutics
Organization:
United Therapeutics